Company profile

Benevolent

Benevolent is a London-based artificial intelligence company focused on drug discovery and development. Since its inception, the company has raised $282 million across multiple funding rounds, including a significant $90 million Series C round, to build and scale its AI-driven biomedical research platform. Benevolent applies generative AI and machine learning to uncover disease mechanisms, identify drug targets, and accelerate therapeutic development across human and veterinary medicine.

Back to profiles

Quick facts

Total funding: $282 million

Reach buyers like Benevolent on TexAu

TexAu helps go-to-market teams find, enrich, and reach companies that match this profile. Pick the path that fits how you work.

Find companies like Benevolent
Build a list by industry, headcount, funding stage, or technographics. Get verified emails and direct dials.
Start a free workspace
Enrich your CRM with company data
Push funding, headcount, hiring signals, and tech stack into HubSpot, Salesforce, or a spreadsheet. Waterfall enrichment.
See how the waterfall works
Run it on a schedule
Refresh the list weekly, score new accounts as they land, and push the ones that fit to Smartlead, Instantly, Lemlist, HeyReach, or Apollo Sequences.
See how schedulers work

Reach buyers like Benevolent.

The 14-day trial ships every feature, no card required.

Start free →